Zymeworks Inc (ZYME)
14.48
-0.02
(-0.14%)
USD |
NASDAQ |
Dec 27, 16:00
14.76
+0.28
(+1.93%)
After-Hours: 20:00
Zymeworks Research and Development Expense (Quarterly): 36.35M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Pfizer Inc | 2.598B |
Ligand Pharmaceuticals Inc | 5.675M |
Cellectar Biosciences Inc | 5.494M |
Revance Therapeutics Inc | 11.38M |
CNS Pharmaceuticals Inc | 4.245M |